TW200613552A - Mutant interleukin-15 polypeptides - Google Patents
Mutant interleukin-15 polypeptidesInfo
- Publication number
- TW200613552A TW200613552A TW094127389A TW94127389A TW200613552A TW 200613552 A TW200613552 A TW 200613552A TW 094127389 A TW094127389 A TW 094127389A TW 94127389 A TW94127389 A TW 94127389A TW 200613552 A TW200613552 A TW 200613552A
- Authority
- TW
- Taiwan
- Prior art keywords
- polypeptides
- mutant
- mutant interleukin
- interleukin
- polypeptide
- Prior art date
Links
- 102000003812 Interleukin-15 Human genes 0.000 title abstract 4
- 108090000172 Interleukin-15 Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2086—IL-13 to IL-16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5443—IL-15
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60047804P | 2004-08-11 | 2004-08-11 | |
| US60104204P | 2004-08-11 | 2004-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200613552A true TW200613552A (en) | 2006-05-01 |
Family
ID=35839987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094127391A TW200619227A (en) | 2004-08-11 | 2005-08-11 | Mutant interleukin-15-containing compositions and suppression of an immune response |
| TW094127389A TW200613552A (en) | 2004-08-11 | 2005-08-11 | Mutant interleukin-15 polypeptides |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094127391A TW200619227A (en) | 2004-08-11 | 2005-08-11 | Mutant interleukin-15-containing compositions and suppression of an immune response |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20060057102A1 (zh) |
| AR (2) | AR050293A1 (zh) |
| TW (2) | TW200619227A (zh) |
| WO (2) | WO2006017853A2 (zh) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1586585A1 (de) * | 2004-04-14 | 2005-10-19 | F. Hoffmann-La Roche Ag | Expressionssystem zur Herstellung von IL-15/Fc-Fusionsproteinen und ihre Verwendung |
| TW200619227A (en) * | 2004-08-11 | 2006-06-16 | Hoffmann La Roche | Mutant interleukin-15-containing compositions and suppression of an immune response |
| PL1899364T5 (pl) | 2005-05-17 | 2024-12-09 | University Of Connecticut | Kompozycje i sposoby immunomodulacji w organizmie |
| JP5709356B2 (ja) | 2006-01-13 | 2015-04-30 | アメリカ合衆国 | 哺乳動物細胞における発現のためのコドン最適化ＩＬ−１５およびＩＬ−１５Ｒ−α遺伝子 |
| EP1921452A1 (en) * | 2006-11-08 | 2008-05-14 | Medizinische Hochschule Hannover | Method for the diagnosis of leukemia |
| KR100888022B1 (ko) | 2006-12-21 | 2009-03-09 | 재단법인 목암생명공학연구소 | 면역글로불린 Ｆｃ와 인간 아포리포단백질（ａ）크링글절편의 융합단백질 ＬＫ8Ｆｃ |
| US20110020269A1 (en) * | 2007-05-08 | 2011-01-27 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for modifying t cell immune responses and inflammation |
| AU2008269032B2 (en) | 2007-06-27 | 2013-12-05 | Novartis Ag | Complexes of IL-15 and IL-15Ralpha and uses thereof |
| CA2799608C (en) * | 2009-05-28 | 2023-02-28 | Richard H. Weisbart | Amino acid sequences which enhance peptide conjugate solubility |
| NZ714757A (en) | 2009-08-14 | 2018-07-27 | Us Gov Health & Human Services | Use of il-15 to increase thymic output and to treat lymphopenia |
| CA2925201A1 (en) * | 2013-09-24 | 2015-04-02 | Massachusetts Institute Of Technology | Self-assembled nanoparticle vaccines |
| MA39711A (fr) * | 2014-04-03 | 2015-10-08 | Nektar Therapeutics | Conjugués d'une fraction d'il-15 et d'un polymère |
| CA2963989A1 (en) * | 2014-10-14 | 2016-04-21 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
| EP3350205A1 (en) * | 2015-09-16 | 2018-07-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Specific interleukin-15 (il-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases |
| US12233104B2 (en) | 2015-10-08 | 2025-02-25 | Nektar Therapeutics | Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist |
| US20180360977A1 (en) * | 2015-12-21 | 2018-12-20 | Armo Biosciences, Inc. | Interleukin-15 Compositions and Uses Thereof |
| CA3029813A1 (en) | 2016-06-13 | 2017-12-21 | Torque Therapeutics, Inc. | Methods and compositions for promoting immune cell function |
| SI3558369T1 (sl) * | 2016-12-21 | 2025-06-30 | Cephalon Llc | Protitelesa, ki se specifično vežejo na človeški il-15, in njihova uporaba |
| CU24546B1 (es) * | 2016-12-30 | 2021-09-07 | Ct Ingenieria Genetica Biotecnologia | Composición vacunal que comprende un mutante de la interleucina-15 humana |
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| US12036283B2 (en) | 2017-05-15 | 2024-07-16 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods |
| KR20210032924A (ko) | 2017-09-05 | 2021-03-25 | 토크 테라퓨틱스, 인코포레이티드 | 치료용 단백질 조성물 및 그의 제조 및 사용 방법 |
| TW202442671A (zh) | 2018-02-26 | 2024-11-01 | 美商欣爍克斯公司 | Il-15結合物及其用途 |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | ANTI-CD19 CHEMERIC ANTIGEN RECEPTORS AND THEIR USE IN IMMUNOTHERAPY |
| KR20220012296A (ko) | 2019-05-20 | 2022-02-03 | 싸이튠 파마 | 암 또는 감염성 질환 치료를 위한 IL-2/IL-15Rβγ 작용제 투여 요법 |
| US20230028399A1 (en) * | 2020-01-13 | 2023-01-26 | Nkarta, Inc. | Bcma-directed cellular immunotherapy compositions and methods |
| US20230390361A1 (en) | 2020-10-26 | 2023-12-07 | Cytune Pharma | Il-2/il-15r-beta-gamma agonist for treating squamous cell carcinoma |
| KR20230096047A (ko) | 2020-10-26 | 2023-06-29 | 싸이튠 파마 | 비흑색종 피부암 치료용 IL-2/IL-15Rβγ 작용제 |
| CN117597355A (zh) | 2021-06-23 | 2024-02-23 | 赛腾制药 | 白细胞介素15变体 |
| CA3225815A1 (en) | 2021-08-13 | 2023-02-16 | Cytune Pharma | Il-2/il-15rbetagamma agonist combination with antibody-drug conjugates for treating cancer |
| CN113956346B (zh) * | 2021-10-26 | 2024-03-01 | 西安龙腾景云生物科技有限公司 | 一种重组白介素-15变体 |
| US20230151095A1 (en) | 2021-11-12 | 2023-05-18 | Xencor, Inc. | Bispecific antibodies that bind to b7h3 and nkg2d |
| WO2024102636A1 (en) | 2022-11-07 | 2024-05-16 | Xencor, Inc. | Bispecific antibodies that bind to b7h3 and mica/b |
| WO2024215987A1 (en) | 2023-04-14 | 2024-10-17 | Sotio Biotech Inc. | IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES |
| WO2024215989A1 (en) | 2023-04-14 | 2024-10-17 | Sotio Biotech Inc. | ENGINEERED IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-2/IL-15 RECEPTOR βγ AGONISTS |
| US20250243279A1 (en) | 2023-10-17 | 2025-07-31 | Xencor, Inc. | Bispecific antibodies that bind to nkp46 and mica/b |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5078997A (en) * | 1988-07-13 | 1992-01-07 | Cetus Corporation | Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
| US5962406A (en) * | 1991-10-25 | 1999-10-05 | Immunex Corporation | Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
| US5795966A (en) * | 1995-02-22 | 1998-08-18 | Immunex Corp | Antagonists of interleukin-15 |
| CA2252557A1 (en) * | 1996-04-26 | 1997-11-06 | Beth Israel Deaconess Medical Center, Inc. | Antagonists of interleukin-15 |
| US6451308B1 (en) * | 1996-04-26 | 2002-09-17 | Beth Israel Deaconess Medical Center | Antagonists of interleukin-15 |
| US20050123542A1 (en) * | 2003-11-06 | 2005-06-09 | Genmab A/S | Methods for treating disorders involving monocytes |
| TW200619227A (en) * | 2004-08-11 | 2006-06-16 | Hoffmann La Roche | Mutant interleukin-15-containing compositions and suppression of an immune response |
| AU2005335217A1 (en) * | 2004-10-05 | 2007-02-15 | Ochsner Clinic Foundation | Enhancement of B cell proliferation by IL-15 |
-
2005
- 2005-08-11 TW TW094127391A patent/TW200619227A/zh unknown
- 2005-08-11 AR ARP050103371A patent/AR050293A1/es not_active Application Discontinuation
- 2005-08-11 WO PCT/US2005/028677 patent/WO2006017853A2/en not_active Ceased
- 2005-08-11 US US11/202,287 patent/US20060057102A1/en not_active Abandoned
- 2005-08-11 AR ARP050103369A patent/AR050693A1/es unknown
- 2005-08-11 US US11/201,585 patent/US20060057680A1/en not_active Abandoned
- 2005-08-11 WO PCT/US2005/028713 patent/WO2006020849A2/en not_active Ceased
- 2005-08-11 TW TW094127389A patent/TW200613552A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060057102A1 (en) | 2006-03-16 |
| AR050293A1 (es) | 2006-10-11 |
| AR050693A1 (es) | 2006-11-15 |
| WO2006020849A3 (en) | 2006-10-05 |
| WO2006017853A2 (en) | 2006-02-16 |
| US20060057680A1 (en) | 2006-03-16 |
| WO2006017853A3 (en) | 2007-01-04 |
| WO2006020849A2 (en) | 2006-02-23 |
| TW200619227A (en) | 2006-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200613552A (en) | Mutant interleukin-15 polypeptides | |
| MXPA06000365A (es) | Aditivo alimentario que comprende variantes de exoamilasa no maltogenica de pseudomonas. | |
| EA200870131A1 (ru) | Варианты ил-12p40 с улучшенной стабильностью | |
| MX2007003078A (es) | Compuestos de imidazoquinolina. | |
| WO2004111217A3 (en) | Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products | |
| CA108023S (en) | Lawn-mower | |
| SG163572A1 (en) | Compositions and methods for eliciting an immune response to escape mutants of targeted therapies | |
| AU300162S (en) | Toaster grill | |
| IL187317A (en) | Preparations containing polypeptide complexes of il-15 and il-15ra for use in enhancing proliferation of training cells | |
| GB2429207A9 (en) | Modified human interferon polypeptides and their uses | |
| NL300605I2 (zh) | ||
| WO2008079290A3 (en) | Stable buffered formulations containing polypeptides | |
| AU301519S (en) | Noise canceller | |
| BR0306905A (pt) | Vacinas de flavivìrus | |
| SG165339A1 (en) | Incorporation of non-naturally encoded amino acids into proteins | |
| AU302369S (en) | Pedicure station I | |
| GB0320020D0 (en) | Improved formulation for providing an enteric coating material | |
| WO2005120564A3 (en) | Vaccine compositions and methods | |
| WO2007078879A3 (en) | Lipopeptide compositions and methods of use thereof | |
| AU301470S (en) | Container | |
| AU301469S (en) | Container | |
| SE0401086D0 (sv) | Iron-based powder composition | |
| DE602005025938D1 (zh) | ||
| ITRM20020550A0 (it) | Proteine mutanti dell'alfa-l-fucosidasi termofile e termostabili in grado di essere prodotte per via ricombinante. | |
| AU306515S (en) | Infant attire |